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Introduction
This is my first year of training upon the recipient of the Predoctoral Traineeship Award from the Army Breast Cancer Research Program. The focus has been mainly on getting training in basic molecular biology experimental techniques and bioinformatics analysis of microarray and genome-wide chromatin immunoprecipitation data. Successful initial research results have been accepted for publication. I am now able to apply my skills to a new interdisciplinary research project where the role of NFκB in endocrine-resistant breast cancer will be studied using microarray dataset and computational models.
Body
The initial training has been focused on receive training on experimental techniques in ERα-bound and E 2 -regulated genes are grouped into four distinct classes. Among up-regulated genes, 29 were rapidly induced and the level remained relatively constant afterward, 8 were induced in a time-dependent manner; and 12 were induced followed by a rapid decay. E 2 -induced genes represent 10.5% of total ERα-bound genes in the promoter-proximal region. Only 5 ERα-bound genes were down-regulated by E 2 , which represent 1.1% of total ERα-bound genes in the promoter-proximal region.
Correlation of gene expression with promoter occupany by PolII and histone modification markers was visualized by constructing the binary map using hierarchical clustering analysis ( Figure 3 ). ERα bound promoters were identified at p < 0.0001 in E 2 -induced MCF7 cells by a novel, highly sensitive genome-wide chromatin immunoprecipitation method, ChIP-DSL. We evaluated the time-course of regulated gene expression by RNA profiling and identified 879 genes that responded to E 2 -induction in MCF7 cells, which generally agrees with other published gene expression profiling studies. Strikingly, only 54 out of these 879 E 2 -affected genes were bound by ERα  in the promoter proximal region (Figure 3 ), indicating that the majority of E 2 -induced genes might be indirectly affected or regulated by ER responsive elements (EREs) located away from the promoter proximal region. Among these 879 E 2 -regulated genes, 562 were up-regulated and 317 were down-regulated. ERα-bound and E 2 -regulated genes are grouped into four distinct classes. Among up-regulated genes, 29 were rapidly induced and the level remained relatively constant afterwards; 8 were induced in a time-dependent manner; and 12 were induced followed by a rapid decay.
E 2 -induced genes represent 10.5% of total ERα-bound genes in the promoter-proximal region. Only 5 ERα-bound genes were down-regulated by E 2 , which represent 1.1% of total ERα-bound genes in the promoter-proximal region ( Figure 4 Figure 6 ). Significantly, this patient group exhibited a much reduced survival rate compared to the two other groups ( Figure 6 ). 
INTRODUCTION
Ligand-dependent activation of large transcriptional gene programs that are simultaneously regulated by nuclear receptors provides critical strategies for development and homeostasis of all metazoans, and its misregulation is associated with many types of disease. Regulated transcription by nuclear receptors is mediated by ligands binding to the C-terminal domain, thus causing conformational changes; these include a change in the position of the so-called AF2 helix, which favors association with specific coactivator complexes and functional conversion of the receptor to an activator (reviewed in . Thus, when unliganded, nuclear receptors, such as the thyroid hormone (T 3 ) and the retinoid acid (RA) receptors, act as repressors primarily by recruiting specific corepressor complexes via the ''CoRNR'' domain (Horlein et al., 1995; Chen and Evans, 1995; Heinzel et al., 1997; Privalsky, 2004) , but, when liganded, they are functionally converted to activators by recruiting coactivator complexes. In addition, for many nuclear receptors, such as estrogen receptor a (ERa) and androgen receptor (AR), other signaling pathways can cause similar recruitment of coactivators and the consequent functional conversion to transcriptional activators even in the absence of ligand (Culig et al., 1994; Nazareth and Weigel, 1996; Zwijsen et al., 1997; Rogatsky et al., 1999; Ueda et al., 2002; Ogawa et al., 2004; . Therefore, it is of particular interest to further explore the linkage between the recruitment of nuclear receptors and the coregulatory complexes that underlie ligand-dependent and -independent activation of transcriptional programs. Most coregulatory complexes exhibit a diversity of enzymatic activities that can be divided into two generic classes: enzymes capable of remodeling the structure of the nucleosome in an ATP-dependent manner and enzymes capable of covalently modifying histone tails; this latter group includes acetylating and deacetylating activities (HATs and HDACs); methylating and demethylating activities (HMTs and HDMs); kinases and phosphatases; poly(ADP)ribosylases; and ubiquitin and SUMO ligases (reviewed in Narlikar et al., 2002; . The histone code model Jenuwein and Allis, 2001) suggests that serial posttranslational histone modifications, such as acetylation, methylation, phosphorylation, and sumoylation, correlate with the specific activated or repressed status of the promoter (reviewed in Peterson and Laniel, 2004; Margueron et al., 2005) . Presumably, the deposition and removal of these marks correspond to a large variety of coregulatory complexes that act in a sequential and combinatorial fashion to ultimately determine spatial and temporal control of gene expression (reviewed in McKenna and O'Malley, 2002; . One of these marks, the histone lysine methylation, was initially considered as a permanent posttranslational modification that exerts long-term epigenetic memory (reviewed in Kouzarides, 2002; Lachner and Jenuwein, 2002) . However, recent data demonstrating the existence of lysine demethylase activities have dramatically challenged this model (Shi et al., 2004; Metzger et al., 2005; Tsukada et al., 2006; Yamane et al., 2006; Whetstine et al., 2006) .
Histone lysine methylation has been extensively linked to both gene activation and gene repression events in euchromatic and heterochromatic regions (reviewed in Lachner and Jenuwein, 2002; Martin and Zhang, 2005) . A large number of SET-domain-containing enzymes, including RIZ1, ESET, Eu-HMTase1, G9a, Suv39h1/h2, MLL1, and others, have been shown to transfer methyl groups to histones and to transcription factors; in particular, this has been shown at multiple lysine residues in histones, including H3-K4, K9, K27, K36, K79, H4-K20, and H1-K26, all of which have been reported in most cases to be mono-, di-, and trimethylated (reviewed in Martin and Zhang, 2005) . It has been proposed that methyl groups may act as binding sites for a wide range of chromatin proteins, including the repressive heterochromatin protein 1 (HP1), which has been reported to bind methyl groups on histone H3 at lysine 9 (H3-K9; Nielsen et al., 2001) , as well as the transcriptional activator WDR5 and the ATP-dependent chromatin-remodeling protein CDH1, which have been reported to bind methyl groups on H3 at lysine 4 (H3-K4; Wysocka et al., 2005; Dou et al., 2005; Flanagan et al., 2005) .
Recently, a CoREST corepressor complex component (Tong et al., 1998; Andres et al., 1999; Ballas et al., 2001; Humphrey et al., 2001; You et al., 2001; Hakimi et al., 2002 Hakimi et al., , 2003 Lunyak et al., 2002; Shi et al., 2003) known as LSD1/BHC110/KIAA0601/p110b was identified as the first histone lysine demethylase, which is involved in mediating neuron-restrictive silencing factor (NRSF)/ REST-dependent repression of neuronal genes in nonneuronal cells (Shi et al., 2004 (Shi et al., , 2005 . In vitro, LSD1 specifically demethylates mono-and dimethylated H3-K4, which, in vivo, has been suggested to mediate gene repression by maintaining an unmethylated H3-K4 status on a specific set of regulated promoters (Shi et al., 2004 (Shi et al., , 2005 . Interestingly, the demethylase activity of LSD1 has been shown to be modulated by other proteins, including CoREST and BHC80 (Shi et al., 2005; Lee et al., 2005) , and by other histone marks displayed around the substrate (Forneris et al., 2005 (Forneris et al., , 2006 . Furthermore, LSD1 has been implicated in H3-K9 demethylation that is associated with PSA gene activation in an ARdependent manner (Metzger et al., 2005) and has been described as a component of the MLL1 coactivator complex (Nakamura et al., 2002) . More recently, additional demethylase enzymes have been described and include JHDM1, which specifically demethylates dimethyl histone H3 at lysine 36 (H3-K36; Tsukada et al., 2006) , JMJD1A/ JHDM2A, which demethylates mono-and dimethyl H3-K9 (Yamane et al., 2006) , and JMJD2A, which demethylates trimethyl H3-K9/K36 (Whetstine et al., 2006) . These enzymes belong to a large family of proteins that contain a conserved JmjC domain, which has been shown to be critical for demethylation (Trewick et al., 2005; Tsukada et al., 2006) . Together, these recent discoveries suggest an important but still mostly unknown role exerted by demethylation events in regulated gene transcription.
Here we report an unexpectedly widespread recruitment of the histone demethylase LSD1 to active promoters, including most ERa gene targets in MCF7 cells, and we find that LSD1 is needed for activation and is required to oppose the functions of three HMTs: RIZ1, ESET, and Eu-HMTase1. For gene transcription, these HMTs exert an inhibitory gatekeeper function, which is required to prevent recruitment of unliganded nuclear receptors and constitutive activation. Intriguingly, a similar molecular strategy is also employed for ERa gene targets that do not recruit LSD1 but utilize distinct combinations of HMTs and HDMs to provide promoter specificity to this HMT/HDM code. A similar code appears to exist also for a number of other signal-dependent transcription programs. In summary, we propose that a gatekeeper strategy imposed by a selective use of HMTs and HDMs is widely exploited in mammalian biology to determine the appropriate physiological amplitude of regulated gene transcription as orchestrated by nuclear receptors and other classes of DNA-binding transcription factors.
RESULTS
A Broad Genome-Wide LSD1 Promoter-Binding Program Detected by ChIP-DSL Based on our interest in the role of corepressor complexes in gene transcription regulation, we applied a new genome-wide chromatin immunoprecipitation (ChIP) assay based on DSL (DNA selection and ligation; details in Supplemental Experimental Procedures and in Kwon et al., 2007) to several CoREST corepressor complex components, including the specific histone lysine demethylase LSD1. Recruitment of LSD1 in MCF7 cells that had been treated with 17 b-estradiol (E 2 ) was determined by the ChIP-DSL method using a specific a-LSD1 antibody (Figure S1 ) and an array containing 20,045 human-proximal promoters (Hu20K; Figure 1A ). Statistical significance for promoter enrichment was based on the analysis of a genomic tiling component included on the array ( Figure 1A , yellow dots). Based on data obtained from three independent biological replicates, we unexpectedly detected a total of 4212 LSD1-enriched (LSD1 + ) promoters in these cells (22% of the Hu20K array that showed reliable signals) even at a highly stringent selection criteria (p < 0.0001), while 118 promoters were detected with an irrelevant antibody using the same criteria ( Figures 1A and 1B , red dots). The number of LSD1 + promoters would increase to 5174 promoters (27% of the array) or 6570 promoters (34% of the array) if the selection criteria were relaxed to a more conventional stringency (p < 0.001 and p < 0.01, respectively; Figure 1C ). These results were validated by conventional ChIP assay and quantitative PCR (qPCR) analysis on randomly selected LSD1 + promoters at p < 0.0001 ( Figure 1D ). Consistent with the predictive value of this assay, virtually all known LSD1-target promoters represented on the Hu20K array were detected as LSD1 + , including the repressed SYN1 (Hakimi et al., 2002) and SCN3A (Shi et al., 2004) promoters ( Figure S2 ). The multiple experimentally confirmed or computationally predicted NRSF/ REST-target genes found as LSD1 + (e.g., CX36, DNM1, PAX4, and SYT2; Andres et al., 1999; Ballas et al., 2001; Hakimi et al., 2002; Lunyak et al., 2002 ; Figure S3A ) and the enrichment of NRSF/REST-predicted sites observed in LSD1 + neuronal-specific genes ( Figure S3B ) are consistent with the model that, as a component of the CoREST complex, LSD1 is functionally important in negatively regulating neuronal NRSF/REST-dependent genes in nonneuronal cells (Andres et al., 1999; Ballas et al., 2001 Ballas et al., , 2005 Humphrey et al., 2001; You et al., 2001; Hakimi et al., 2002; Lunyak et al., 2002; Shi et al., 2003 Shi et al., , 2004 Bruce et al., 2004) .
Broad LSD1 Promoter Binding Is Primarily Associated with Gene Activation Events
In addition to the role of LSD1 in transcriptional repression (Figures S2 and S3) , $84% of LSD1 + promoters were Pol II + and, quite unexpectedly, a full 42% of all Pol II + promoters in MCF7 cells were LSD1 + ( Figure 1E ). These results were confirmed by conventional ChIP/qPCR assay ( Figure 1F ). Similarly, examination of histone marks was consistent with the preponderance of activated, rather than repressed, LSD1 + promoters. Indeed, dimethylation of histone H3 lysine 4 (diMeH3K4), a substrate for LSD1 demethylation activity associated with LSD1 repressive functions (Shi et al., 2004 (Shi et al., , 2005 Lee et al., 2005) , and acetylation of histone H3 lysine 9 (acH3K9), another wellestablished mark that correlates with gene activation, exhibited a considerable overlapping pattern with the presence of LSD1 on gene promoters ( Figure 1G ). These observations were corroborated by clustering ChIP-DSL and mRNA-profiling data sets obtained in MCF7 cells, thus observing $74% LSD1 + genes as expressed (Figures 1G and 1H) . Taken together, our data suggest that the percentage of activated transcription units modulated by LSD1 ($74%-84%) is substantially larger than the percentage of activated transcription units ($16%-26%) included in the LSD1-repressed program ( Figures 1E and 1H ). Recently, we identified 578 promoters that exhibit ERa binding in MCF7 cells . Surprisingly, 58% of ERa-enriched (ERa + ) promoters also exhibited LSD1 recruitment (319 ERa + /LSD1 + promoters); these represented $9% of all LSD1 + promoters ( Figure 2A ). In addition, genomic tiling analysis using ChIP-DSL assay of two well-established ERa-regulated target genes, TFF1/pS2 and GREB1, revealed LSD1-and ERa-corecruitment on presumed ERa-binding enhancer sites that were located $10 Kb upstream of TFF1/pS2 and $40 Kb upstream of GREB1 gene start sites ( Figure 2B ). This ChIP-DSL analysis also showed that an ERa coactivator, CBP, and an ''activation'' histone mark, AcH3K9, exhibited similar profiles ( Figure 2B ). For all factors tested, including LSD1, the occupancy on both distal and proximal promoter cognate DNA sites was shown to be stimulated by E 2 treatment as determined by ChIP/qPCR ( Figure 2C ). In addition, LSD1 recruitment on promoters of other LSD1 + /ERa + -target genes was also stimulated by E 2 ( Figure 2D ). In agreement with these data, coimmunoprecipitation experiments in whole MCF7 cell extract using a-LSD1 antibody demonstrated a specific E 2 -dependent interaction of LSD1 with endogenous ERa and CBP, and vice versa ( Figures 2E and 2F ). of LSD1 had no effect on its ligand-dependent activation ( Figure 3C ).
To test the role of the amine oxidase activity of LSD1 on regulation of LSD1 + /ER + targets, a rescue experiment was performed by single-cell nuclear microinjection assay; in this experiment, wild-type human LSD1 (wt hLSD1) or a predicted amine oxidase-inactive human form (mut hLSD1) was injected in Rat-1 cells that were simultaneously depleted of the endogenous rat LSD1 by microinjection of rLSD1siRNA. While WT hLSD1 rescued the E 2 -induced activation of a pS2 promoter LacZ reporter, the mut hLSD1 was unable to rescue the reporter gene activity ( Figure 3D ). Similarly, transient transfection of wt hLSD1 but not mut hLSD1 caused an E 2 -dependent increase in the activity of an ERE-Luc reporter ( Figure S5 ). Therefore, the amine oxidase activity, which was proven to be required for mediating LSD1-dependent H3-K4 and H3-K9 demethylation (Shi et al., 2004; Metzger et al., 2005) , is also necessary for LSD1/ERa-dependent gene activation.
We next addressed any H3-K4 and H3-K9 demethylation event that might occur upon E 2 stimulation of LSD1/ ERa-dependent gene targets. While ERa binding and acH3K9 were increased as a result of E 2 treatment (Figures 3E and 3F ), we observed, by quantitative ChIP/ qPCR on promoter and distal pS2 and GREB1 ERa-target sites, a consistent decrease in both diMeH3K4 and diMeH3K9 ( Figures 3G and 3H) . Importantly, no simultaneous increases in trimethylation status were observed on the same sites ( Figures 3I and 3J ). In concert, these findings suggest that H3-K9 and H3-K4 methylation dynamics are key components of the gene activation program mediated by LSD1.
Mechanisms Underlying the LSD1-Dependent Gene Activation
To understand the mechanism underlying the functional requirement for LSD1 in E 2 -dependent induction, we examined the impact of removing various H3-K9 and H3-K4 HMTs (Martin and Zhang, 2005) by siRNA on E 2 -dependent induction. Depletion of known H3-K4 HMTs, including MLL1, had little effect on basal pS2 activity (data not shown). However, depletion of several specific H3-K9 HMTs, including RIZ1, ESET, and Eu-HMTase1, but not G9a or Suv39h1/h2, derepressed the pS2 promoter; this resulted in full activation in the absence of ligand ( Figure 4A ), while no significant effects were observed after depletion of these three enzymes in the presence of ligand ( Figure 4B ). Thus, in the absence of these specific H3-K9 HMTs, regulated activation of pS2 gene now became LSD1 independent ( Figure 4C ). Consistent with these observations, mRNA levels of endogenous pS2 and GREB1 genes were upregulated upon siRNAmediated RIZ1/ESET depletion even in the absence of ligand without any effect on response observed in the presence of ligand ( Figures 4D, 4E , and S4B). To demonstrate the specificity in knockdown experiments, we observed at least a partial ($70%) functional rescue of the repressive ESET activity in HeLa cells in which the endogenous human ESET (hESET) was depleted by specific hESET siRNA, and the mouse form of this HMT (mESET) was overexpressed ( Figure 4F ). In addition, the binding of ESET and RIZ1 on pS2 and GREB1 promoters was found to be decreased upon E 2 stimulation as quantified by ChIP/qPCR ( Figure 4G ). Together, these data suggest that a critical function of LSD1 is to reverse the inhibitory effect of several H3-K9 HMTs: RIZ1, ESET, and EuHMTase1, the presence of which dictates LSD1 dependency for gene activation. (D) Functional rescue analysis of the wild-type (wt) and the amine oxidase mutant (mut) human LSD1 form (hLSD1) in Rat-1 cells is shown. Endogenous rat LSD1 (rLSD1) expression was depleted by specific rat LSD1 siRNA, and ectopic wt hLSD1 and mut hLSD1 overexpression was accomplished by expression plasmids. Reporter plasmid and LSD1 siRNA were delivered by single-cell nuclear microinjection in Rat-1 cells.
(E-J) Panels show ChIP/qPCR occupancy analysis of ERa (E), acH3-K9 (F), diMeH3-K4 (G), diMeH3-K9 (H), TriMeH3-K4 (I), and TriMeH3-K9 (J) on ERa-binding sites in vehicle-or E 2 -treated MCF7 cells. ERa proximal or distal binding sites on pS2 and GREB1 genomic loci were examined; HIG2 promoter was included as control. The data in (A)-(J) are the average of three replicates, and error bars represent ± standard error mean.
The requirement for more than one H3-K9 HMT implies that, at least for some genes, these enzymes are not fully functionally redundant; this has also been recently shown for similar nonredundant HDM activities (Yamane et al., 2006) . Interestingly, at least one of the specific H3-K9 HMTs, RIZ1, has been proposed to act as a tumor-suppressor gene that is silenced in many highly metastatic breast cancer cell lines (He et al., 1998; Du et al., 2001) , and RIZ1 siRNA-depleted MCF7 cells showed increased levels of cell proliferation (Carling et al., 2004; Gazzerro et al., 2006) . Indeed, cell proliferation and cell-cycle control were the top two ER + gene ontology-enriched terms that were revealed by ChIP-DSL analysis of ERa in MCF7 cells , suggesting a global upregulation of ER + gene targets in the absence of RIZ1. Because of the connection between specific protein kinases, including CaMKs, and the actions of repressive HMTs (Ishitani et al., 2003; Zhang, et al., 2002; Kurahashi et al., 2005) , we tested the possibility that CaMKII might modulate H3-K9 HMTs and, hence, LSD1-and E 2 -dependent gene activation events. Interestingly, specific CAMKIIg siRNA resulted in full, LSD1-independent activation of the pS2-reporter gene ( Figure 4H ), which strongly suggests a link between specific signaling pathways and an HMT-dependent imposition of inhibitory histone marks.
A Balance between Histone Lysine Methylation and Demethylation Events Determines Ligand Dependency of ERa Targets
The observation of ''ligand-independent'' gene activation in the absence of specific H3-K9 HMTs raised the question of whether ERa is still critically required for activation in the absence of these enzymes and LSD1. To investigate this issue, siRNA depletion of ERa, along with RIZ1 or ESET, was performed in MCF7 cells and revealed that, in the absence of ERa, pS2 promoter activation was abolished ( Figure 5A ). These results, which are fully in concert with the observation that unliganded ERa can still bind to and even recycle at low levels on the pS2 promoter (Metivier et al., 2004; Perissi et al., 2004) , were confirmed on endogenous ERa-target genes ( Figures 5B and 5C ).
ChIP analysis of RIZ1/ESET siRNA-depleted cells showed an increased recruitment of ERa, in absence of E 2 , to a level equivalent to that observed with E 2 , thus supporting the hypothesis that one critical function of H3-K9 HMTs is to inhibit recruitment of unliganded ERa to its target genes ( Figure 5D ). Furthermore, well-established ERa coactivators, including CBP and SRC1-p/CIP, were required for this LSD1-and ligand-independent activation ( Figure 5E ). In contrast, the depletion of these same HMTs caused neither activation (data not shown) nor increased ERa binding on the LSD1-independent ERa target WISP2 promoter (Figure 5D ), suggesting a role of other combinations of HMTs/HDMs in ERa regulation of LSD1-independent genes (see below).
Based on the broad recruitment of LSD1 on proximal promoters ( Figure 1C) , we determined the LSD1 dependency of several additional regulated gene activation programs. LSD1 siRNA microinjection experiments revealed a similar role of LSD1 in activation of AR, as previously shown (Metzger et al., 2005; Yamane et al., 2006) . In addition, these experiments revealed a role of LSD1 in activation of NFkB-, AP-1-, and bRAR-regulated promoters, but not in the case of CREB-regulated gene targets ( Figure S6 ). These data suggest that LSD1 is selectively involved in induction of a subset of regulated transcription units but is not universally required for gene activation. Analogous to ERa, RIZ1 and ESET appeared to exert a similar role in AR-dependent activation of the PSA gene ( Figures 6A and S7A) as suggested by the partial derepression of PSA expression levels and the LSD1-independent activation of the same gene, which were again produced in the absence of specific H3-K9 HMTs. Similarly, depletion of RIZ1/ESET resulted in activation of NFkB-target genes in absence of signal, and this activation also exhibited dependency on the presence of NFkB factors (Figures S7B-S7D ). Based on these data, we propose that a major biological role for the opposing actions of RIZ1/ESET/Eu-HMTase1 and LSD1 is to confer high amplitude of ligand response or signal dependency of gene activation on cohorts of regulated transcription units.
Promoter-Specific HMT/HDM ''Code'' for Regulated Transcription Units Because pS2 and GREB1 require LSD1 for activation, while WISP2 does not, a key question is whether entirely distinct molecular strategies are used for LSD1 + -and LSD1 À -regulated transcription units or whether distinct HMTs and HDMs are required to mediate a similar regulatory mechanism. As a new AR-specific H3-K9 HDM, JMJD1A/JHDM2A, has recently been reported (Yamane et al., 2006) , we examined whether this enzyme exerts a similar role on LSD1 + /ERa-regulated targets and, alternatively, whether this factor might substitute for LSD1 on LSD1 À /ERa + gene targets. The specific depletion of JMJD1A by siRNA in LNCaP cells confirmed that this factor was required for ligand-dependent activation of ARtarget genes ( Figures 6B and 6C) , as previously shown (Yamane et al., 2006) . Because LSD1 is also required ( Figure 6A ; Metzger et al., 2005) , these AR-target genes demonstrate that at least two HDMs are required for full activation (Yamane et al., 2006) . In contrast, ERa-dependent activation of pS2 and GREB1 gene targets depends on LSD1 but not on JMJD1A when similar experiments are performed in MCF7 cells (Figures 6D-6F) . Interestingly, however, an unexpected activation of the pS2 promoter was observed in the absence of ligand (Figures 6D-6F ). Based on these findings, we next explored whether an LSD1 À /ERa + gene target, WISP2, might use JMJD1A and HMTs other than ESET/RIZ1/EuHMTase to mediate a strategy of regulation similar to that utilized by LSD1 and these enzymes for pS2. Interestingly, while LSD1 siRNA did not inhibit ligand-dependent activation ( Figure 3C ), JMJD1A siRNA blocked E 2 -dependent stimulation of WISP2 ( Figure 6G ), and G9A but not SUV39H1/H2 siRNAs permitted a partial activation ($50%) in the absence of ligand ( Figure 6H ). Together, these results provide compelling evidence for a widely used, promoterspecific code in regulated transcription, with different cohorts of targets requiring distinct combinations of HMTs and HDMs. It is interesting to note that for some genes, loss of HMTs alone causes a level of activation similar to that observed in response to ligand, while for others, only a partial activation, with further enhancement when ligand is present, is observed.
DISCUSSION
Here we report an unexpected mechanism that proves to be physiologically utilized to prevent constitutive gene activation by unliganded nuclear receptors and other classes of signal-dependent DNA-binding transcription factors. We have identified three specific H3-K9 HMTs that potentially act as gatekeepers for the $58% of ERa gene targets that are LSD1 + and that maintain a repressive status that precludes unliganded nuclear receptors, such as ERa, from effective binding and from functioning as ligand-independent, constitutive activators ( Figure 6I ). Indeed, transcriptional activation by unliganded nuclear receptors has been reported on removal of corepressors and on activation by specific signaling pathways (Culig et al., 1994; Nazareth and Weigel, 1996; Zwijsen et al., 1997; Rogatsky et al., 1999; Ueda et al., 2002; Ogawa et al., 2004; .
Our data support the model that inhibitory HMTs prevent unregulated activation of these targets, at least in part, by blocking the binding of unliganded ERa to its cognate DNA sites. The binding of liganded ERa on these regulated promoters thereafter permits the recruitment of the LSD1 enzymatic activity that is required to dismiss the inhibitory marks and, potentially, methyl marks of other nonhistone substrates (I.G.-B. and M.G.R., unpublished results), thus permitting other ERa-recruited coactivators to initiate the regulated transcriptional response ( Figure 6I ). Thus, exchange of inhibitory histone lysine methyl marks based on the actions of specific, and not fully redundant, H3-K9 HMTs as well as the actions of critical HDMs are required to permit a ligand-dependent response. Therefore, while REST/CoREST-dependent genes clearly employ LSD1 in repression for at least a cohort of the REST-dependent program (Shi et al., 2004; Figures S2 and S3) , our results have also revealed that LSD1, most likely associated with the MLL1 complex (Nakamura , 2002; Guenther et al., 2005) , is required for a surprisingly broad range of regulated gene activation events. We further suggest that the HMT/HDM cycle provides a licensing mechanism for signal-dependent gene activation of other classes of regulated transcription factors that are required for normal development and homeostasis.
Gene-Specific Use of HMT/HDMs to Define Regulated Gene Activation Programs
Because LSD1 is recruited only to a subset of ERa-target genes, we were keen to initially examine the possibility that a similar inhibitory histone code and degree of HMT/ HDM usage might act on genes even when LSD1 is not recruited to the promoter. Recently it has been reported that the mono-and dimethyl H3-K9 HDM, JMJD1A/JHDM2A, contributes with LSD1 to the hormone-induced H3-K9 demethylation of the PSA promoter/enhancer (Metzger et al., 2005; Yamane et al., 2006) , and that an additional H3-K9 demethylase, JMJD2A, displays specific trimethyl H3-K9/K36 activity (Whetstine et al., 2006 Figure 6J ). For example, the LSD1 À /ERa + WISP2-target gene requires JMJD1A for ligand-dependent activation, in which G9a is selectively required to prevent ligand-independent constitutive activation. However, LSD1 but not JMJD1A is necessary for E 2 -dependent activation of the ERa + -target genes pS2 and GREB1, while both LSD1 and JMJD1A are required for DHT activation of the KLK2 and PSA genes. It is therefore tempting to speculate that there will be multiple cohorts of target genes for each nuclear receptor that depend on a similar strategy to prevent constitutive activation, but each will utilize unique combinations of HMTs and HDMs to license ligand-regulated expression.
While we would predict the existence of additional substrates other than H3-K9, for H3-K9 HMTs, and H3-K4/K9, for LSD1, we propose that ultimately the inhibitory gatekeeper strategy that is imposed by different HMTs blocks ligand-independent receptor binding and constitutive gene activation. This gatekeeper function is biologically overcome on binding of liganded receptors and specific H3-K9 HDMs. The requirement for three different HMTs, RIZ1/PRDM5 (Steele-Perkins et al., 2001), ESET/SETDB1 (Yang et al., 2002; Schultz et al., 2002; Wang et al., 2003) , and Eu-HMTase1/GLP (Ogawa et al., 2002) , for at least some ERa-target genes, suggests that these SET-domain enzymes are not fully functionally redundant (Schultz et al., 2002; Wang et al., 2003) , as seems to similarly occur for at least two HDMs, LSD1 and JMJD1A/JHDM2A, for the regulation of some AR-target genes (Metzger et al., 2005; Yamane et al., 2006) . As this represents an analogous strategy involving different HMTs and HDMs, the link between histone marks in preventing constitutive activation of physiologically regulated genes appears to be a general strategy.
H3-K4 and H3-K9 Demethylation in E 2 -Dependent Gene Activation At least two different dimethylated lysines have been proposed to be demethylated by LSD1: the well-documented H3-K4 (Shi et al., 2004 (Shi et al., , 2005 Lee et al., 2005) and H3-K9 (Metzger et al., 2005) . LSD1 was found by ChIP-DSL to be mainly associated with the presence of dimethyl H3-K4 on the genome ( Figure 1G) . Indeed, although a certain degree of H3-K4 demethylase activity was observed upon activation of ERa targets, high remaining levels of this mark were still observed after LSD1 binding and activation, which would agree with the high overlapping pattern detected ( Figure 3G ). In contrast, it is proposed that this mark is fully removed by LSD1 on targets that are repressed by NRSF, which is supposed to confer gene repression (Shi et al., 2004) . Thus, LSD1 might switch activity depending on the promoter, which is consistent with the ability of CoREST and BHC80 to modify LSD1 enzymatic activity in vitro (Shi et al., 2005; Lee et al., 2005) , therefore displaying H3-K4 demethylase on NRSF targets and H3-K9 demethylase on AR, ERa, and other factors' target promoters. Also, one of the two reported LSD1 activities might be selectively inactivated by the surrounding histone marks present around the promoter. Indeed, specific histone marks, such as AcH3-K9, inhibit H3-K4 demethylation in vitro (Forneris et al., 2005 (Forneris et al., , 2006 . Of course, both activities could be also equally utilized on all promoters, with the final levels of histone methylation being indeed determined by the predemethylation levels.
The regulatory roles of these two histone methylation marks on gene activation of euchromatic promoters have been the subject of intense investigation during the past few years. For example, methylation of H3-K9 has been described to decrease on a subset of inflammatory genes upon LPS stimulation (Saccani and Natoli, 2002) . Similarly, an inverse relationship between H3-K9 methylation and NFkB p65 binding on the IL-1b promoter has been observed upon LPS stimulation in THP-1 cells (Chan et al., 2005) . Dimethylation of H3-K9 but also H3-K4 has been described to decrease when T 3 R shifted from an unliganded state to a liganded, active state (Li et al., 2002) , and a dramatic decrease in H3-K4 occurred on a tandem array of the mouse mammary tumor virus (MMTV) promoter upon induction by glucocorticoids (Ma et al., 2001 ). Finally, a decline in both dimethyl H3-K4 (Kim et al., 2003) and dimethyl H3-K9 (Metzger et al., 2005) has been reported on the PSA promoter upon DHT induction, and here we show that both histone marks are simultaneously decreased upon ERa/E 2 -dependent activation of several promoters. Thus, dynamic changes of H3-K4 and H3-K9 methylation seem to occur in a diversity of programs.
In conclusion, an important aspect of the serial posttranslational methylation modifications of histones and transcription factors, which constitute a component of the hypothesized ''histone code,'' is to impose signal/ligand dependency to regulated DNA-binding transcription factors by modulatory binding of unliganded receptors and other classes of transcription factors, thereby preventing constitutive activation of cohorts of target genes.
EXPERIMENTAL PROCEDURES

Materials and Reagents
Anti-LSD1 antibody was generated in guinea pigs against bacterially expressed N 0 -terminal region (13-219 aa) of the human LSD1.
Anti-CoREST antibody was a generous gift from Dr. Gail Mandel.
Commercially available antibodies and siRNAs are documented in Supplemental Data.
ChIP Assay MCF7 breast cancer cells were hormone deprived for 4 days and then treated for 1 hr with 100 nM 17b-estradiol (E 2 ). ChIP assay was conducted as previously described . Further details and list of primers used for PCR validation are available in Supplemental Data.
ChIP-DSL Assay
Genome-wide promoter location analysis by ChIP-DSL on Hu20K and HuTiling arrays was performed and analyzed as described in Supplemental Experimental Procedures and in Kwon et al., 2007 . Biological triplicates were performed in each case.
Single-Cell Nuclear Microinjection Assay
The small interfering RNAs (siRNAs) were delivered into cells by singlecell microinjection assay as previously described (Kamei et al., 1996; Heinzel et al., 1997) . Details and siRNA information are available in Supplemental Experimental Procedures.
Transient Transfection Assay
Transient transfection assay in MCF7 cells was performed using Lipofectamin 2000, following manufacturer's protocol (Invitrogen).
RNA Isolation, Real-Time PCR, and RNA Profiling Analysis RNA was extracted by RNeasy Assay (Qiagen), and cDNA was obtained by SuperScript First-Strand Synthesis System (Invitrogen) following both manufacturers' protocols. RNA profiling was performed as described by Kwon et al., 2007 . Further details and list of primers used for PCR amplification are available in Supplemental Experimental Procedures.
Immunoprecipitation
Immunoprecipitation assay was conducted as previously described (Bannister and Kouzarides., 1996) . Details are available in Supplemental Experimental Procedures. Contributed by Michael G. Rosenfeld, January 26, 2007 (sent for review January 22, 2007) ChIP coupled with microarray provides a powerful tool to determine in vivo binding profiling of transcription factors to deduce regulatory circuitries in mammalian cells. Aiming at improving the specificity and sensitivity of such analysis, we developed a new technology called ChIP-DSL using the DNA selection and ligation (DSL) strategy, permitting robust analysis with much reduced materials compared with standard procedures. We profiled general and sequence-specific DNA binding transcription factors using a full human genome promoter array based on the ChIP-DSL technology, revealing an unprecedented number of the estrogen receptor (ER␣) target genes in MCF-7 cells. Coupled with gene expression profiling, we found that only a fraction of these direct ER␣ target genes were highly responsive to estrogen and that the expression of those ER␣-bound, estrogen-inducible genes was associated with breast cancer progression in humans. This study demonstrates the power of the ChIP-DSL technology in revealing regulatory gene expression programs that have been previously invisible in the human genome.
Real-Time qPCR
breast cancer ͉ genome-wide ͉ promoter array T he elucidation of genomes for humans and other model organisms has made it possible to conduct analysis of gene expression and regulation at the genome scale. Gene expression is generally accompanied by chromatin remodeling activities and histone modifications. An important conceptual advance has been the ''histone code'' hypothesis, which suggests that histone modifications reflect a sequential action of enzymes associated with the transcriptional machinery such that one prior activity may influence the next during regulated gene expression (1, 2) . Histone acetylation results in charge neutralization of modified lysines, which is generally associated with gene activation (3) . In contrast, histone methylation on different residues appears to provide binding sites for specific transcription regulators, thereby positively or negatively affecting gene expression (4) . Although histone methylation may modulate gene expression in a gene-specific and context-dependent manner, certain site-specific modifications appear to be generally applicable to most genes. The epigenetic markers thus provide a roadmap to identify and characterize functional DNA elements in the genome.
The nuclear receptor (NR) superfamily of transcriptional regulators plays a central role in many developmental and disease processes, and the system has been extensively studied as a model to learn the mechanism for spatial and temporal control of gene expression (5) . Individual NRs have consensus binding sites in promoters and enhancers, which have been characterized in detail, but only in a limited number of NR-regulated genes. In the case of the pS2 gene (also known as TFF1), for example, binding by estrogen receptor ␣ (ER␣) initiates sequential recruitment of a large number of transcription factors onto the promoter to start transcription (6) . However, despite extensive mechanistic insights in transcriptional initiation in this and other well studied cases, little is known about how many genes are direct targets for an NR. Genome-wide ChIP coupled with microarray, known as ChIP-onchip, offers a solution to this problem by determining promoters bound directly by transcription factors (7) (8) (9) (10) . Surprisingly, however, recent promoter and tiling array analyses suggest that ER␣ binds relatively rarely to gene promoters compared with intergenic regions, suggesting a critical role of long-distance enhancers in regulated gene expression in mammalian cells (11) (12) (13) .
Here we describe an approach to detecting in vivo DNA-protein interactions by coupling ChIP with a DNA selection and ligation (DSL) strategy, permitting analysis of many fewer cells than required by the conventional ChIP-on-chip method. We constructed a full genome promoter array based on this ChIP-DSL platform, and our analysis revealed that ER␣ bound to Ͼ3% of human genes in promoter-proximal regions in MCF-7 cells, reinforcing the importance of direct binding events in the promoter-proximal regions during regulated gene expression. Results from built-in tiling arrays allowed direct visualization of binding events even without statistical filtering of raw data, and a comprehensive histone modification profile extended the current histone code hypothesis. These results demonstrate the versatility and accuracy of the ChIP-DSL technology in a genome-wide search for direct target genes by specific transcription factors and in comprehensive analysis of regulatory programs within specific genomic loci. Furthermore, comparison between profiles of ER␣ binding and 17␤-estradiol (E 2 )-induced gene expression in MCF-7 cells revealed a subset of genes whose expression tracks breast cancer progression in humans, which not only suggests the prognostic value of these genes as biomarkers for breast cancer but also illustrates a general strategy for dissecting molecular pathways in cancer. 
Results and Discussion
Design and Development of the ChIP-DSL Technology. Aiming to detect functional DNA elements with high sensitivity and specificity, we devised a multiplex assay by coupling ChIP with a DSL approach (Fig. 1) . A signature 40-nt sequence is first computationally identified in a genomic segment 0.5-1 kb in length. For promoter profiling each such probe corresponds to a proximal promoter region from ϩ200 nt to Ϫ800 nt relative to the transcription start, which contains Ϸ95% of known binding sites for transcription factors in humans (8) . To construct a tiling array, each probe is used to represent an Ϸ0.5-kb nonrepetitive genomic block in a path to be tiled. This probe density takes into account the number of probes required for maximal coverage of genomic sequences and the sufficiency in detecting immunoprecipitated DNA, which is generally sheared to an average length of 0.5-1 kb. Amine-modified 40-mers are spotted onto solid support to form an array.
Corresponding to each 40-mer, a pair of assay oligonucleotides are synthesized, each consisting of the two 20-mer halves in the 40-mer and flanked by a universal primer landing site. Multiple oligonucleotide pairs are mixed to form a pool. The assay begins with standard ChIP, and the isolated DNA is randomly biotinylated followed by annealing to the oligonucleotide pool. Annealed oligonucleotides are selected on streptavidin-conjugated magnetic beads, and unannealed oligonucleotides are washed away. This selection strategy allows the use of an excessive amount of oligonucleotides to achieve maximal annealing that follows the pseudofirst-order kinetics and prevents interference of later steps by excess free oligonucleotides in solution. All selected oligonucleotides are immobilized, and those paired by specific target DNA are ligated, thereby converting only correctly targeted oligonucleotides to full amplicons for PCR amplification. One of the PCR primers is end-labeled with a fluorescent dye so that the PCR products can be directly hybridized to the 40-mer array.
This technology is distinct from the conventional ChIP-on-chip assay in several key aspects. First, chromatin immunoprecipitated DNA was used to template oligonucleotide ligation, instead of being directly amplified for hybridization. This step can tolerate incomplete decross-linking because cross-linking adducts should have less effect on oligonucleotide hybridization than signal amplification by a polymerase. Second, we targeted only unique signature sequences in the human genome, thereby avoiding potential interference of repetitive and related sequences during hybridization. Third, the sensitivity is significantly elevated by PCR amplification of ligated oligonucleotides in an unbiased fashion because all amplicons contain the same pair of specific primer landing sites and are uniform in length as previously documented (14) .
We progressively enlarged the multiplicity of the assay to eventually cover most annotated gene promoters in the human genome. Titration experiments indicate that the ChIP-DSL technology could routinely operate with cells from one-third of a single 100-mm culture dish, which corresponds to 1-5 ϫ 10 6 cells, depending on the cell type under investigation. Despite the fact that each promoter is targeted by one oligonucleotide pair, high-quality data generated as reported in this and other studies (15) demonstrate the reproducibility and robustness of the ChIP-DSL technology.
We initially assessed promoters potentially active in transcription based on their association with RNA polymerase (Pol) II in E 2 -treated MCF-7 cells (Fig. 2A) . Anti-Pol II-enriched (Pol II ϩ ) promoters (red) were clearly segregated from background marked by built-in tiling array controls (yellow), finding that 43% of total promoters were Pol II ϩ at a standard P value Ͻ 0.001. Quantitative ChIP/quantitative PCR (qPCR) analysis of randomly selected promoters suggests a false positive rate of Ϸ3% and a false negative rate of Ϸ33% [ Fig. 2B and supporting information (SI) Fig. 6 ]. A similar false positive rate was observed by using an irrelevant IgG (SI Fig. 7A ). The false negative rate is quite similar to that reported in published ChIP-chip studies (16) . Pol II ϩ promoters were also marked by AcH3K9 (98%), Me 2 H3K4 (98%), and Me 3 H3K4 (88%), although a significant fraction of promoters were associated only with these gene activation marks, but not with Pol II (Fig. 2C) . In contrast, the ''repressive'' histone mark Me 3 H3K27 was detected in only a small fraction (10%) of Pol II ϩ promoters. Indeed, this repressive histone mark has been shown to associate with some active genes (17) . An RNA profiling experiment in the same E 2 -stimulated MCF-7 cells showed that most Pol II ϩ promoters were actively transcribing (Fig. 2D) . Collectively, these robust and highly consistent data testify to the utility and sensitivity of the ChIP-DSL technology.
Identification of ER␣-Occupied Gene Promoters in the Human Genome. We next applied the ChIP-DSL technology to identify target genes for sequence-specific DNA-binding transcription factors. ER␣ plays an important role in human reproduction and breast cancer. Recent promoter profiling analysis using 1-kb promoter regions detected 153 ER␣-bound promoters (13) . Further, tiling analysis of ER␣ binding suggests that ER␣ binds prevalently to intergenic regions in the human genome, suggesting a new paradigm that estrogen-regulated gene expression may be largely driven by long-distance enhancers (11, 12) . Complimentary to these recent genomic analyses, we scored Ϸ1,300 anti-ER␣-enriched (ER␣ ϩ ) promoters in E 2 -stimulated MCF-7 cells based on the single-array error model (9) at the standard cutoff of P Ͻ 0.001, and Ϸ700 at a more stringent cutoff of P Ͻ 0.0001 (Fig. 3A) . A significant number of ER␣ ϩ promoters were also identified in vehicle-treated MCF-7 cells, suggesting a class of hormone-independent recruitment events (SI Fig. 7B ). To identify ER␣ ϩ promoters with high statistical confidence, we analyzed the data from multiple biological repeats using three statistical methods that are based on distinct mathematical principles, revealing an overlapping set of 578 highest confidence ER␣ ϩ promoters, which represents 3.3% of all reliably scored promoters ( Fig. 3B and SI Data Set 1).
ChIP/qPCR analysis confirmed all ER␣ ϩ promoters examined, including those residing in chromosomes 21 and 22 ( Fig. 3C ) and 20 additional promoters in other chromosomes (data not shown), indicating a negligible false positive rate for anti-ER␣ ϩ -enriched promoters supported by stringent statistical tests. Estimation of the false negative rate proved to be challenging when the majority of the probes are in the ''negative'' population (8) . We used ChIP/qPCRconfirmed promoters recently reported (13) to objectively estimate our false negative rate. Among 27 validated promoters common between the two array platforms, 20 were scored positive in our array at P Ͻ 0.0001 and 24 at P Ͻ 0.001, indicating that our false negative rate is Ϸ26% and 11% at the two P value cutoffs, respectively, which is probably an overestimate, because three promoters (CYP4F3, PROP1, and ABCG2) not detected were enriched only Ͻ2-fold in previous ChIP/qPCR experiments (13) .
Together, these results demonstrate the accuracy of the ChIP-DSL data and conservatively identify Ϸ4-fold as many ER␣ target promoters as were detected in previous genome-wide location analysis, suggesting that the promoter array based on the ChIP-DSL technology is a useful resource for the general research community.
We next conducted motif analysis using a newly refined algorithm, which compares ChIP-enriched promoters against normalized nucleotide frequencies in all promoters (C.B. and C.K.G., unpublished data), revealing a highly enriched, but uncharacterized, motif associated with ER␣-bound promoters (Fig. 3D ). When this motif was masked, the next most enriched motifs were the classic ER␣-binding consensus sequences (18) , which are present in 44% of the total ER␣ ϩ promoters (Fig. 3D) . Interestingly, whereas the algorithm confirmed the presence of FoxA1 recognition motifs surrounding a fraction of intergenic ER␣ binding sites (11) , it did not detect extensive association of the FoxA1 binding site with the The first motif appears common to gene promoters in general, but the protein(s) recognizing this motif is unknown. When this motif is masked, the most enriched motif corresponds to full-or half-consensus estrogen responsive element. Allowing one base mismatch, the percentage of promoters containing a full-or half-consensus estrogen responsive element among total ER␣-bound promoters was calculated and shown in Right.
ER␣
ϩ promoters identified by ChIP-DSL. In light of the finding that FoxA1 is critical for ER␣ binding to several target genes examined (11, 13) , it will be interesting to determine in future studies whether FoxA1 is selectively or universally required for ER␣ targeting.
Locus-Specific Tiling Array Analysis of ER␣ Binding and Histone
Modifications. To facilitate data analysis of promoter arrays, we built in a number of tiled loci to serve as internal negative controls because not all genomic regions are expected to be occupied by general and sequence-specific DNA binding transcription factors. The data in turn illustrate the usefulness of the ChIP-DSL technology in revealing specific molecular recognition events that constitute the regulatory programs in individual genomic loci. As illustrated in Fig. 4 , we found that ER␣ bound to the promoter (filled arrow) and a putative enhancer (open arrow) of the TFF1 gene, as previously reported (11) . The transcriptional coactivator CBP similarly interacted with both promoter and enhancer, whereas Pol II covered the body of this relatively small gene. In the case of the GREB1 gene, we observed a similar pattern with ER␣, CBP, and Pol II present on two of the three promoters that were previously characterized (19) . Interestingly, we found that all three factors interacted with three distinct loci upstream of the GREB1 promoters, suggesting that these sites may function as enhancers. These observations are consistent with a large body of literature that gene promoters and enhancers are recognized by sequencespecific DNA-binding transcription factors, which in turn recruit transcription coactivators.
Acetylated histone (AcH3K9) was observed in both promoters and enhancers in TFF1 and GREB1 as expected. Histone 3 lysine-4 methylation is generally associated with active genes, but the profile of individual modifications is significantly distinct: Me 1 H3K4 seems to associate broadly with active genes, but, in contrast to the situation in yeast, this modification is not preferentially linked to the 3Ј end of active genes (2, 20, 21 was found exclusively in promoters, which agrees with most mapping studies in yeast and mammalian cells (20, 22, 23) . Interestingly, AcH3K9 and methylated H3K4 marks were present in a number of gene promoters, including KAI1 (Fig. 4) , where no RNA transcripts were detected in MCF-7 cells. These observations suggest either that some histone modifications take place before the recruitment of the general transcriptional machinery or that these genes may be transcribing at an undetectable basal level. Although one cannot formally distinguish between these possibilities, the histone modification pattern is clearly different from ''silent'' genes such as RAR␤ (Fig. 4) . The RAR␤ promoter was specifically marked by Me 3 H3K27, which is generally associated with silent genes in heterochromatin (24) . Thus, there is heterogeneity in marks of nonexpressed genes exemplified by the observation that the KAI1 promoter is accessible to transcription factors, whereas the RAR␤ promoter is actively repressed in MCF-7 cells.
To further characterize histone modifications associated with gene repression, we mapped Me 2 H3K79 and Me 3 H3K9 (Fig. 4) . Me 2 H3K79 has been previously implicated in interactions with Sir proteins during gene silencing (25, 26) , although a more recent study suggested a link of this modification to gene activation (27) . We found that Me 2 H3K79 was indeed associated with active genes, but in a distinct, gene-specific manner. In the case of TFF1, this modification took place in the transcribing region near the promoter, whereas in the case of GREB1, Me 2 H3K79 was spread in the entire transcription unit, including both coding and promoter/ enhancer regions. Me 3 H3K9 has also been previously linked to gene repression by serving as the binding site for HP1 to facilitate the assembly of heterochromatin (25, 26, (28) (29) (30) . Here we found that Me 3 H3K9 decorated most 3Ј transcribed regions of both TFF1 and GREB1, consistent with a role of this specific histone modification in transcription elongation as recently suggested in yeast (31) . These findings illustrate that it is still quite precipitous to generalize the significance of most histone modification events with respect to gene activation or repression, as the same histone modification may reflect or influence transcription positively or negatively in a highly gene-specific and locus-dependent manner, consistent with a combinatorial histone code.
Expression of Direct ER␣ Target Genes in Breast Cancer Cells and
Tissues. While the majority of ⌭R␣-bound promoters were also marked by Pol II and epigenetic markers associated with gene activation (Fig. 5A) , we evaluated the time course of regulated gene expression by RNA profiling and identified 879 genes that responded to E 2 -induction in MCF-7 cells, which generally agrees with other published gene expression profiling studies (32) (33) (34) . Strikingly, only 54 of these 879 E 2 -affected genes were bound by ER␣ in the promoter-proximal region (Fig. 5B) , indicating that the majority of E 2 -induced genes might be indirectly affected or regulated by ER-responsive elements located away from the promoterproximal region. Among these 879 E 2 -regulated genes, 562 were up-regulated and 317 were down-regulated. Contrary to the expectation that a similar percentage of genes in these two categories would be targeted by ER␣ in the promoter-proximal region, we found that 49 (10.5%) of ER␣-bound promoters were up-regulated by E 2 , whereas only 5 (1.1%) were down-regulated ( Fig. 5 B and C) . These observations suggest that many genes in both up-and down-regulated categories might be indirectly affected, with more down-regulated genes influenced by indirect mechanisms than up-regulated ones (35) .
Conversely, the fact that only 54 ER␣-bound promoters responded to E 2 with rapid changes in mRNA levels suggests that most ER␣-bound promoters may require additional cofactors for E 2 -dependent gene expression, as has been previously documented (36) (37) (38) (39) . Consequently, we predicted that different sets of ER␣-occupied promoters might respond to E 2 stimulation in different cell types. Indeed, we have found that a subset of ER␣-bound, but E 2 -insensitive, promoters in MCF-7 cells could be directly targeted by ER␣ and induced by E 2 in U2OS cells stably expressing ER␣ (data not shown). This observation suggests that, at least for some promoters, they represent bona fide estrogen target genes under different circumstances.
To further investigate the biological relevance of ER␣-binding and estrogen-regulated gene expression, we asked how the newly identified 54 E 2 -responsive ER␣ target genes might be differentially regulated in breast cancer tissues using a comprehensive set of gene expression profiling data from 251 breast cancer patients (40) . We found a direct correlation between gene expression and tumor progression by unsupervised hierarchical clustering (Fig. 5D ). Patients were clustered into three groups. About half of the genes were strongly suppressed in group 2, which displayed an ER-negative status and advanced tumor grade (Fig. 5D) . Significantly, this Gene expression profiling in response to E2 treatment. ER␣-bound and E2-regulated genes are grouped into four distinct classes. Among up-regulated genes, 29 were rapidly induced, and the level remained relatively constant afterward; eight were induced in a time-dependent manner; and 12 were induced followed by a rapid decay. E2-induced, genes represent 10.5% of total ER␣-bound genes in the promoter-proximal region. Only five ER␣-bound genes were down-regulated by E2, which represent 1.1% of total ER␣-bound genes in the promoter-proximal region. (D) Segregation of ER expression and breast tumor grade (both indicated at the top by blue bars) based on ER␣-bound and E2-induced genes in MCF-7 cells. (E) Kaplan-Meier plots of patient survival in different groups segregated based on ER␣-bound and E2-inducted genes in MCF-7 cells. Statistical significance was determined by the 2 test.
